Integrating UHPLC-Q-TOF-MS/MS and Network Pharmacology to Reveal the Mechanism of Jinbei Oral Liquid in Radiation-Induced Lung Injury with Pulmonary Hypertension
Planta Medica · 30.10.2026
DOI: 10.1055/a-2993-4115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 30.10.2026. Verfasst von Xinru Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Central Hospital Affiliated to Shandong First Medical University, Department of Pharmacy, Shandong, China, Jinan. Gefördert von: National Major Scientific and Technological Special Project for National Key Research and Development Program of China, Natural Science Foundation of Shandong Province of China.
Abstract (Originalsprache)
Pulmonary fibrosis (PF) with pulmonary hypertension (PAH) commonly arises in advanced radiation-induced lung injury (RILI) stages. Jinbei Oral Liquid (JBOL) has certified in clinical studies to enhance pulmonary function indicators and 6MWD in PF patients. The clinical improvement impact on the comorbidity is obvious while its molecular mechanism remains unclear. In this study, Active fraction identification in lung tissues was conducted using UHPLC-Q-TOF-MS/MS. Potential targets of effective active compounds were predicted using TCMSP, SwissTargetPrediction, HERB, GeneCards and DrugBank. JBOL and RILI-PAH targets were obtained from GeneCards, DisGeNET, Harmonizome and GEO dataset. The herb-pathway-target-disease network and PPI of intersection targets were constructed using STRING and Cytoscape. We further performed GO and KEGG enrichment analysis on these targets. Molecular docking was performed to validate the docking activity of the core active compounds and targets. We tentatively annotated 34 prototype lung-inhaled components via UHPLC-Q-TOF-MS/MS. Network pharmacology may potentially alleviate RILI-PAH by utilizing active compounds like Daidzein, Calycosin, Cnidilide, Glycyrrhetinic acid, Hesperidin, Liquiritigenin, and Protocatechualdehyde to modulate targets such as PGF, IGF1, MMP9, MMP8, CCR1, ALOX5AP, and CCND1, and influence signaling pathways like PI3K-Akt, AGE-RAGE, and HIF-1. This intervention could impact inflammatory responses, promote cell migration and motility, and influence cellular reactions to nitrogen compounds. The molecular docking results showed that hesperdin, daidzein, calycosin and Glycyrrhetinic acid have higher affinity with CCR1, MMP8 and ALOX5AP. The results suggest that JBOL may treats RILI-PAH through multiple components and pathways, providing a clinical reference for the principle of treating different diseases with the same method.
Autor:innen und Institutionen
- Central Hospital Affiliated to Shandong First Medical University, Department of Pharmacy, Shandong, China, Jinan.
- Shandong Hongji-tang Pharmaceutical Group Co., Ltd, Institute of Chinese Materia Medica, Shandong, China, Jinan.
- Shandong University of Traditional Chinese Medicine, School of Pharmacy, Shandong, China, Jinan.
ORCID-Profile: Xinru Han
Förderung
- National Major Scientific and Technological Special Project for National Key Research and Development Program of China
- Natural Science Foundation of Shandong Province of China
Zitieren
APA
Han, X., Zhang, X., Zhang, A., Meng, Z., & Li, F. (2026). Integrating UHPLC-Q-TOF-MS/MS and Network Pharmacology to Reveal the Mechanism of Jinbei Oral Liquid in Radiation-Induced Lung Injury with Pulmonary Hypertension. Planta Medica. https://doi.org/10.1055/a-2993-4115
Vancouver
Han X, Zhang X, Zhang A, Meng Z, Li F. Integrating UHPLC-Q-TOF-MS/MS and Network Pharmacology to Reveal the Mechanism of Jinbei Oral Liquid in Radiation-Induced Lung Injury with Pulmonary Hypertension. Planta Medica. 2026. doi:10.1055/a-2993-4115
BibTeX
@article{Han2026,
author = {Han, Xinru and Zhang, Xiang and Zhang, Aijun and Meng, Zhaoqing and Li, Feng},
title = {Integrating UHPLC-Q-TOF-MS/MS and Network Pharmacology to Reveal the Mechanism of Jinbei Oral Liquid in Radiation-Induced Lung Injury with Pulmonary Hypertension},
journal = {Planta Medica},
year = {2026},
doi = {10.1055/a-2993-4115}
}
EUVIMED